| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |